BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cury DB, Cury MS, Elias GVH, Mizsputen SJ. Infliximab to treat severe ulcerative colitis. World J Gastroenterol 2009; 15(14): 1771-1773 [PMID: 19360923 DOI: 10.3748/wjg.15.1771]
URL: https://www.wjgnet.com/1007-9327/full/v15/i14/1771.htm
Number Citing Articles
1
Heidi Waters, Julie Vanderpoel, Scott McKenzie, Orsolya Lunacsek, Meg Franklin, Barbara Lennert, John Goff, Damian H. Augustyn. Stability of infliximab dosing in inflammatory bowel disease: results from a multicenter US chart reviewJournal of Medical Economics 2011; 14(4): 397 doi: 10.3111/13696998.2011.583152
2
Jing Feng, Yueying Chen, Qi Feng, Zhihua Ran, Jun Shen. Novel Gene Signatures Predicting Primary Non-response to Infliximab in Ulcerative Colitis: Development and Validation Combining Random Forest With Artificial Neural NetworkFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.678424
3
Ane Søgaard Teisner, Mark A Ainsworth, Jørn Brynskov. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: A Danish single center experienceScandinavian Journal of Gastroenterology 2010; 45(12): 1457 doi: 10.3109/00365521.2010.510572
4
Qi Lv, Yao Xing, Yijun Liu, Qingzhu Chen, Jingyi Xu, Lihong Hu, Yinan Zhang. Didymin switches M1-like toward M2-like macrophage to ameliorate ulcerative colitis via fatty acid oxidationPharmacological Research 2021; 169: 105613 doi: 10.1016/j.phrs.2021.105613
5
Maryam Fareed Ashoor. Infliximab Induced Leukoencephalopathy and Peripheral Neuropathy: A Case Report and a Review of LiteratureJournal of Neurology & Stroke 2018; 8(1) doi: 10.15406/jnsk.2018.08.00274
6
De-Jun Cui. Early aggressive therapy for severe extensive ulcerative colitisWorld Journal of Gastroenterology 2009; 15(33): 4218-4219 doi: 10.3748/wjg.15.4218
7
Emily C. L. Wong, Shahin Merat, Cristina Monaco, Parambir S. Dulai, Vipul Jairath, John K. Marshall, Walter Reinisch, Neeraj Narula. Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched StudyDigestive Diseases and Sciences 2023; 68(6): 2635 doi: 10.1007/s10620-023-07956-8